The once-daily human GLP-1 analogue liraglutide improves both absolute and baseline corrected postprandial glucose levels

被引：0
|
作者：
Flint, A. [1 ]
Kapitza, C. [2 ]
Hindsberger, C. [1 ]
Zdravkovic, M. [1 ]
机构：
[1] Novo Nordisk AS, Global Dev, DK-2880 Bagsvaerd, Denmark
[2] Profil Inst Stoffivechselforsch GmbH, Neuss, Germany
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
887
引用
收藏
页码：S354 / S354
页数：1
相关论文
共 50 条
  • [11] New Aspects to the Once-Daily GLP-1 Mimetic Liraglutide
    Schneider, S.
    DIABETES STOFFWECHSEL UND HERZ, 2009, 18 (05): : 395 - 402
  • [12] Effects of the once-daily human GLP-1 analogue liraglutide on appetite and energy intake in type 2 diabetes
    Horowitz, M.
    Flint, A.
    Doran, S.
    Rasmussen, M. F.
    Kapitza, C.
    Andreasen, A. H.
    Jones, K. L.
    Zdravkovic, M.
    Chapman, I. M.
    DIABETOLOGIA, 2008, 51 : S355 - S355
  • [13] The molecular basis for the delayed absorption of the once-daily human GLP-1 analoge, liraglutide
    Steensgaard, Dorte B.
    Thomsen, Jens K.
    Olsen, Helle B.
    Knudsen, Lotte B.
    DIABETES, 2008, 57 : A164 - A164
  • [14] Liraglutide: A Review of the First Once-Daily GLP-1 Receptor Agonist
    Bode, Bruce
    AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (02): : S59 - S70
  • [15] Safety, tolerability, pharmacokineties and pharmacodynamics of the once-daily GLP-1 analogue liraglutide in healthy Japanese subjects
    Irie, Shin
    Matsumura, Yoriko
    Zdravkovic, Milan
    Jacobsen, Lisbeth V.
    Kageyama, Shigeru
    DIABETES, 2007, 56 : A540 - A540
  • [16] Liraglutide, the once-daily human GLP-1 analogue, has a protracted profile based on both delayed absoprtion and a long plasma half-life
    Knudsen, L. Bjerre
    Nielsen, P. F.
    Steensgaard, D. B.
    Bloch, P.
    Lau, J.
    Agersoe, H.
    DIABETOLOGIA, 2009, 52 : S305 - S306
  • [17] Liraglutide, a once-daily human GLP-1 analog, significantly improves β-cell function in subjects with type 2 diabetes
    Matthews, David
    Marre, Michel
    Le-Thl, T. U. Duyen
    Zdravkovic, Milan
    Simo, Rafael
    DIABETES, 2008, 57 : A150 - A151
  • [18] The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance
    Lykkegaard, Kirsten
    Larsen, Philip J.
    Vrang, Niels
    Bock, Camilla
    Bock, Troels
    Knudsen, Lotte Bjerre
    SCHIZOPHRENIA RESEARCH, 2008, 103 (1-3) : 94 - 103
  • [19] Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes
    Ryan, Gina J.
    Hardy, Yolanda
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) : 260 - 274
  • [20] Erratum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide
    A Astrup
    R Carraro
    N Finer
    A Harper
    M Kunesova
    M E J Lean
    L Niskanen
    M F Rasmussen
    A Rissanen
    S Rössner
    M J Savolainen
    L Van Gaal
    International Journal of Obesity, 2012, 36 : 890 - 890
12345